 LEIDEN, Netherlands CAMBRIDGE, Mass., Nov. 02, 2020 GLOBE NEWSWIRE -- ProQR Therapeutics N.V. Nasdaq:PRQR, a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced virtual poster presentations at the Annual Meeting of the American Academy of Ophthalmology AAO held November 13-15, 2020. 